AWARENESS PROJECT
Designed as a recurring broadcast platform, RLT-Channel spotlights different cancer types one at a time and explores how radiotheranostics can play a role in their treatment. Each episode combines global perspectives on the state of the field with a closer look at local realities, eligibility pathways, and referral processes, giving patients, families, and healthcare professionals a clear and practical view of what RLT can offer today.
The RLT-Channel is designed for everyone touched by a cancer journey. People living with cancer and their loved ones can find clear, reassuring explanations to help them understand their options and feel more confident in conversations with their care team. And the wider public gains access to expert-led content that demystifies a rapidly evolving field of cancer care.
Episode 1: Prostate Cancer's New Hope: RLT in Action, Global and Belgium Focus
This first episode is dedicated to individuals living with prostate cancer and their loved ones. It demystifies radioligand therapy by offering clear and practical information on how the therapy works, its potential benefits, and how it can be integrated into the care pathway.
The episode pairs a global overview with a focused look at the Belgian landscape, helping viewers understand both the broader momentum behind RLT and what access looks like closer to home.
Speakers of Episode 1
Prof. Zéna Wimana, PhD,
Director of Radiopharmacy at Jules Bordet Institute.
Dr. Erik Briers, MS PhD,
President of Europa Uomo & Vice Chairman of Wij Ook vzw
Prof. Dr. Nadia Withofs, MD PhD,
Nuclear Medicine Physician at CHU Liege
Dr. Vincent Vanhaudenarde, MD,
Medical Oncologist at CHU UCL Namur
Episode 2: Understanding Neuroendocrine Cancers & How RLT Can Help Improve Quality of Life
The second episode turns to neuroendocrine tumors (NETs), exploring the latest developments and remaining challenges worldwide while offering a clear overview of current NET care pathways.
Through expert insights and accessible explanations, it highlights the role of radioligand therapy in today's treatment landscape and helps patients and families better understand available care options, eligibility criteria, and referral processes.
Speakers of Episode 2
Prof. Dr. Timon Vandamme,
Digestive and Neuroendocrine Oncologist from the Antwerp University Hospital
Prof. Dr. Loïc Djaïleb,
Head of the Nuclear Medicine Department of the CHU Grenoble Alpes, Oncidium Ambassador
Dirk Van Genechten,
Vice-chairperson and treasurer of the NET & MEN Kanker, Belgian Patients Association
Marie-Noëlle Gheeraert,
Nuclear Medicine Nurse, Treatment coordinator at Jules Bordet Institute
Prof. Dr. Christophe Deroose,
Nuclear Medicine Physician at the KULeuven
Discover our RLT-Channel Serie
Watch it on YoutubeIf you would like to bring a similar broadcast to your region, or contribute expertise to a future episode, we invite you to contact the foundation directly. Together, we can raise awareness and advance access to radiotheranostics worldwide.